1. Introduction {#sec1-molecules-23-00276}
===============

Phytoalexins are antimicrobial secondary metabolites that are produced in plants de novo after pathogen attack \[[@B1-molecules-23-00276]\]. In rice plants, 19 phytoalexins have been reported, including 14 labdane-related diterpenes (momilactones, oryzalexins, and phytocassanes), one casbene-type diterpene (*ent*-10-oxodepressin), one flavanone (sakuranetin), and two amides (*N*-benzoyltryptamine and *N*-cinnamoyltryptamine) \[[@B2-molecules-23-00276]\]. We demonstrated that the rice phytoalexins play an important role in blast disease resistance in rice plants \[[@B3-molecules-23-00276],[@B4-molecules-23-00276],[@B5-molecules-23-00276]\].

Phytopathogenic microorganisms can detoxify phytoalexins to prevent their antimicrobial activities \[[@B6-molecules-23-00276],[@B7-molecules-23-00276],[@B8-molecules-23-00276],[@B9-molecules-23-00276]\]. We have previously reported that the rice diterpenoid phytoalexin momilacotone A and the flavonoid phytoalexin sakuranetin (**1**) can be metabolized and detoxified by the rice blast fungus *Pyricularia oryzae* \[[@B3-molecules-23-00276],[@B5-molecules-23-00276],[@B10-molecules-23-00276],[@B11-molecules-23-00276]\]. The detoxified metabolites of **1** were identified as naringenin (**2**) and sternbin, which are derived from **1** via 7-*O*-demethylation and 3′-hydroxylation, respectively \[[@B10-molecules-23-00276]\].

Rice sheath blight fungus, *Rhizoctonia solani*, is another major fungal pathogen in rice \[[@B12-molecules-23-00276]\], and **1** has been reported to show antifungal activity against *R*. *solani* \[[@B13-molecules-23-00276]\]. We are interested in whether *R*. *solani* can also detoxify **1** and whether the detoxified metabolites are different from those of *P*. *oryzae*. In this study, the detoxified metabolites of **1** were identified from the *R*. *solani* suspension culture. We identified two xylosylated flavanones specific to *R*. *solani*, sakuranetin-4′-*O*-β-[d]{.smallcaps}-xylopyranoside (**3**) and naringenin-7-*O*-β-[d]{.smallcaps}-xylopyranoside (**4**), as well as **2**, which is also a metabolite of *P*. *oryzae*, as the detoxified metabolites of **1** ([Figure 1](#molecules-23-00276-f001){ref-type="fig"}).

2. Results and Discussion {#sec2-molecules-23-00276}
=========================

2.1. Sakuranetin *(**1**)* is Metabolized by Rhizoctonia solani {#sec2dot1-molecules-23-00276}
---------------------------------------------------------------

As shown in [Figure 2](#molecules-23-00276-f002){ref-type="fig"}, the level of sakuranetin (**1**) decreased to almost zero within 9 h in the *R*. *solani* suspension culture. We have already shown that another rice pathogenic fungus, *P*. *oryzae*, can metabolize **1**, which suggested that *R*. *solani* could also metabolize **1**.

We then screened the fungal culture for putative metabolites of **1**. The MeOH extracts from the fungal culture containing **1** after incubation for 0 and 12 h were analyzed by LC-MS. The total ion current chromatograms of each extract were compared ([Figure 3](#molecules-23-00276-f003){ref-type="fig"}). Compound **1** was detected in the 0 h extract at *t*~R~ 22.1 min, whereas only a trace amount of **1** was present in the 12 h extract. Three new peaks were detected at *t*~R~ 17.4 (I), 19.1 (II), and 20.5 min (III) in the 12 h extract. These peaks were not detected in a culture without **1** or in the medium containing **1** without the fungus ([Figure S1](#app1-molecules-23-00276){ref-type="app"}). Therefore, we were certain these peaks were from the possible metabolites of **1**.

2.2. Identification of Naringenin *(**2**)* in the Rhizoctonia solani Suspension Culture Containing Sakuranetin *(**1**)* {#sec2dot2-molecules-23-00276}
-------------------------------------------------------------------------------------------------------------------------

The mass spectrum of peak II showed a plausible \[M + H\]^+^ ion at *m*/*z* 273, which was consistent with the \[M + H\]^+^ of naringenin (**2**). The *t*~R~ of II (19.1 min) coincided that of **2**, which had been identified as a metabolite of **1** by *P*. *oryzae* in our previous study \[[@B10-molecules-23-00276]\]. The *t*~R~ and collision-induced dissociation-mass spectrum (CID-MS) of peak II were compared with those of **2** in LC-MS/MS analysis. The *t*~R~ and CID-MS were consistent as shown in [Figure 4](#molecules-23-00276-f004){ref-type="fig"}. Therefore, we concluded that peak II was from **2**.

2.3. Purification and Identification of Sakuranetin-4′-O-β-[d]{.smallcaps}-xylopyranoside *(**3**)* and Naringenin-7-O-β-[d]{.smallcaps}-xylopyranoside *(**4**)* in Rhizoctonia solani Suspension Culture Containing Sakuranetin *(**1**)* {#sec2dot3-molecules-23-00276}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Peaks I and III showed significant ions at *m*/*z* 273 and 287, respectively, in their electrospray ionization-mass spectra (ESI-MS) ([Figure S2](#app1-molecules-23-00276){ref-type="app"}). The ions are identical to the protonated molecules of **2** and **1**, respectively; however, their *t*~R~s are different from those of **2** and **1**. Therefore, we speculated that peaks I and III are derived from compounds that include naringenin and sakuranetin moieties, respectively.

We then tried to purify compounds **3** (peak III) and **4** (peak II) from the *R*. *solani* suspension culture containing **1** based on LC-MS analysis. Compounds **3** (1.1 mg, a white solid) and **4** (2.4 mg, a yellow oil) were successfully purified from 300 mL of the *R*. *solani* suspension culture containing 10 mg of **1**. Finally, 4.4 mg of **3** and 9.4 mg of **4** were obtained from 50 mg of **1** after several purification steps.

The ESI-MS of **3** showed plausible \[M + H\]^+^ and \[M + Na\]^+^ ions at *m*/*z* 419 and 441, respectively, suggesting a molecular weight of 418 ([Figure S2](#app1-molecules-23-00276){ref-type="app"}). High-resolution mass spectrometry (HRMS) analysis using fast atom bombardment (FAB) ionization of **3** suggested a molecular formula of C~21~H~22~O~9~, which has eleven degrees of unsaturation. The ^13^C NMR and DEPT spectra revealed that **3** has 19 inequivalent carbons; namely, one methyl, two methylenes, nine methines, and seven quaternary carbons ([Table 1](#molecules-23-00276-t001){ref-type="table"}). The ^1^H, ^13^C, HSQC, COSY, and HMBC spectra suggested the structure of sakuranetin is conserved in **3** ([Table 1](#molecules-23-00276-t001){ref-type="table"} and [Figure 5](#molecules-23-00276-f005){ref-type="fig"}). The TOCSY and COSY correlations of the remaining signals and their chemical shifts indicated that a pentose moiety should be present in **3**. The HMBC data suggested that the pentosyl group forms a pentopyranosyl structure, and that the pentopyranosyl group is connected to the oxygen at the 4′-position in sakuranetin.

The pentopyranosyl group in **3** was determined by GC-MS analysis of the hydrolysate of **3**. The hydrolysate of **3** was trimethylsilylated and then subjected to GC-MS. [d]{.smallcaps}-Xylose, [d]{.smallcaps}-ribose, and [l]{.smallcaps}-arabinose, which are common pentoses in natural products, were also trimethylsilylated and analyzed by GC-MS. The chromatograms of the trimethylsilylated (TMS) derivatives of the pentoses showed four peaks, which were indicative of the α-pyranose, β-pyranose, α-furanose, and β-furanose forms of the compounds \[[@B14-molecules-23-00276]\]. The TMS derivative of the hydrolysate of **3** showed four peaks with *t*~R~s that coincided with those of xylose. The mass spectra of the four peaks derived from the hydrolysate of **3** also coincided with those of the xylose derivatives ([Figure S3](#app1-molecules-23-00276){ref-type="app"}). Although the absolute stereochemistry of xylose was not determined experimentally, the [d]{.smallcaps}-form is a reasonable assignment because the [l]{.smallcaps}-form is not known as a natural product. The anomeric position was determined to be in the β-configuration based on the *J* value (7.2 Hz) of H-1″. We therefore concluded that **3** is sakuranetin-4′-*O*-β-[d]{.smallcaps}-xylopyranoside ([Figure 1](#molecules-23-00276-f001){ref-type="fig"}). The stereochemistry of C-2 was not determined in this study.

The ESI-MS of **4** showed a plausible \[M + Na\]^+^ ion at *m*/*z* 427, suggesting a molecular weight of 404 ([Figure S2](#app1-molecules-23-00276){ref-type="app"}). HRMS analysis using FAB ionization of **4** was indicative of a molecular formula of C~20~H~20~O~9~, which includes eleven degrees of unsaturation. Some of the ^13^C NMR signals of **4** were observed as double signals that had very similar, but not identical, chemical shifts ([Table 1](#molecules-23-00276-t001){ref-type="table"}). This suggested that purified **4** was a mixture of two diastereomers. However, the diastereoisomers were not chromatographically separable. We determined **4** was a diastereomeric mixture by a similar manner as we used to determine the structure of **3**. The NMR spectra of **4** revealed that a pentopyranose was connected to the 7-oxygen in naringenin ([Table 1](#molecules-23-00276-t001){ref-type="table"} and [Figure 5](#molecules-23-00276-f005){ref-type="fig"}). GC-MS analysis revealed that the pentose is a xylose moiety ([Figure S4](#app1-molecules-23-00276){ref-type="app"}). We thus concluded that **4** is naringenin-7-*O*-β-[d]{.smallcaps}-xylopyranoside ([Figure 1](#molecules-23-00276-f001){ref-type="fig"}). The difference in the diastereomers must be the stereochemistry of C-2. However, the NMR spectra of **3** indicated that purified **3** seemed to be the single diastereomer. This suggested that *R*. *solani* may preferentially xylosylate a specific enantiomer of **1**.

Naringenin-7-*O*-xyloside was reported as a biotransformation product of naringenin by genetically engineered *Escherichia coli* that could express a glycosyltransferase from *Arabidopsis thaliana* and some other related enzymes \[[@B15-molecules-23-00276]\]. The structure of naringenin-7-*O*-xyloside was confirmed only by LC-MS/MS analysis in that report.

2.4. Accumulation of Naringenin *(**2**)*, Sakuranetin-4′-O-β-[d]{.smallcaps}-xylopyranoside *(**3**)*, and Naringenin-7-O-β-[d]{.smallcaps}-xylopyranoside *(**4**)* in the Rhizoctonia solani Suspension Culture Containing Sakuranetin *(**1**)* {#sec2dot4-molecules-23-00276}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[Figure 6](#molecules-23-00276-f006){ref-type="fig"} shows the time-dependent accumulation of **2**, **3**, and **4** in the *R*. *solani* suspension culture containing **1** (100 µmol/L). The level of **1** decreased to nearly zero in the 9 h after the addition of **1**. The levels of **2**, **3**, and **4** gradually increased in the first 12 h, and the levels were relatively constant until 24 h. This result strongly supported that **2**, **3**, and **4** are products of the metabolism of **1** by *R*. *solani*. The total accumulation of **2**, **3**, and **4** in the suspension culture after 9 h of incubation was 90 µmol/L. Therefore, these three compounds must be the major metabolites of **1** in the *R*. *solani* suspension culture.

We have already reported that **1** can be metabolized by *P*. *oryzae*, and that the metabolites were identified as **2** and sternbin \[[@B10-molecules-23-00276]\]. Compound **2** is a common metabolite to both *P*. *oryzae* and *R*. *solani*, but the xylosylated flavanones, **3** and **4**, are specific to *R*. *solani*. Our previous study demonstrated that the accumulation levels of the metabolites of *P*. *oryzae*, **2** and sternbin, reached their maximum levels after 6--8 h of incubation and then decreased to the almost zero as the incubation time increase to 24 h \[[@B10-molecules-23-00276]\]. However, the levels of the metabolites from *R*. *solani*, **2**, **3**, and **4** did not decrease significantly in 24 h of incubation.

2.5. Antifungal Activities of Naringenin *(**2**)*, Sakuranetin-4′-O-β-[d]{.smallcaps}-xylopyranoside *(**3**)*, and Naringenin-7-O-β-[d]{.smallcaps}-xylopyranoside *(**4**)* {#sec2dot5-molecules-23-00276}
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The antifungal activities of **2**, **3**, and **4** were measured to determine if **2**, **3**, and **4** are detoxified metabolites of **1**. [Figure 7](#molecules-23-00276-f007){ref-type="fig"} and [Table 2](#molecules-23-00276-t002){ref-type="table"} show the antifungal activities of **2**, **3**, and **4** against *R*. *solani*. The antifungal activity of **2** was lower than that of **1**. The antifungal activities of **3** and **4** were almost negligible. This result suggested that *R*. *solani* could detoxify **1** in the suspension culture.

Glucosylation is known to be a common detoxification method for phytoalexins \[[@B6-molecules-23-00276],[@B9-molecules-23-00276]\]. However, to the best of our knowledge, xylosylation detoxification of a phytoalexin has not been reported. We therefore concluded that xylosylation is a rare and efficient mode of detoxification of phytoalexins.

3. Materials and Methods {#sec3-molecules-23-00276}
========================

3.1. General Analytical Methods {#sec3dot1-molecules-23-00276}
-------------------------------

^1^H NMR (400 MHz), ^13^C NMR (100 MHz), and 2D-NMR spectra were acquired on an AVANCE III FT-NMR spectrometer (Bruker BioSpin, Rheinstetten, Germany) equipped with a 5 mm BBFO probe. The chemical shifts were referenced to residual ^1^H or ^13^C signals of the solvents: acetone-*d*~6~ (δ~H~ 2.05; δ~C~ 29.84) or methanol-*d*~4~ (δ~H~ 3.31; δ~C~ 49.00). The UV spectra were acquired using a V-550 spectrometer (Jasco, Tokyo, Japan); the samples for UV spectroscopy were dissolved in MeOH. LC-MS and LC-MS/MS were performed with a 3200 QTRAP LC/MS/MS system (SCIEX, Framingham, MA, USA) coupled with a Prominence UFLC system (Shimadzu Co., Kyoto, Japan). The FAB-MS were recorded with a JMS-BU25 mass spectrometer (Jeol, Tokyo, Japan) in the negative ion mode; glycerol was used as the matrix and argon was used as the FAB gas. Polyethylene glycol was used as an internal standard for HRMS analysis. GC-MS was performed with a JMS-BU25 mass spectrometer coupled with an HP6890 gas chromatograph (Agilent Technologies, Santa Clara, CA, USA). Preparative HPLC was carried out with PU-980 HPLC pumps and an MD-910 photodiode array detector (Jasco).

3.2. Chemicals {#sec3dot2-molecules-23-00276}
--------------

Sakuranetin (**1**) was chemically synthesized from naringenin (**2**; Sigma-Aldrich, St. Louis, MO, USA) according to a previously reported method \[[@B16-molecules-23-00276]\]. The sakuranetin and naringenin used in this study were racemic mixtures. [d]{.smallcaps}-Xylose was purchased from Tokyo Chemical Industry (Tokyo, Japan). [d]{.smallcaps}-Ribose was purchased from Wako Pure Chemical Industries (Osaka, Japan). [l]{.smallcaps}-Arabinose was purchased from Nacalai Tesque (Kyoto, Japan). A Sylon BFT kit (BSTFA + TMCS, 99:1; Supelco, Bellefonte, PA, USA) was used for trimethylsilylation.

3.3. Fungal Material {#sec3dot3-molecules-23-00276}
--------------------

The rice sheath blight fungus (*Rhizoctonia solani* MAFF305003) was obtained from NARO Genebank Project (Tsukuba, Japan) and was maintained on a potato dextrose agar (PDA) medium (Nissui Pharmaceutical, Tokyo, Japan) as a stock culture. A small portion of this stock culture was inoculated and grown on PDA in a Petri dish (9 mm in diameter) at 26 °C in the dark prior to use in the following experiments.

3.4. Incubation of the Rhizoctonia solani Suspension Cultures with Sakuranetin *(**1**)* {#sec3dot4-molecules-23-00276}
----------------------------------------------------------------------------------------

A portion of approximately 1 × 1 cm of the fungal layer was excised from the 5 dpi PDA medium. The fungal layer was homogenized using a spatula and suspended in 50 mL of potato dextrose broth (PDB; Sigma-Aldrich). The fungal culture was incubated for 3 days in the dark at 27 °C with rotary shaking at 150 rpm. A spherical mycelial cluster (approximately 5 mm in diameter) that was formed was transferred to fresh PDB (1 mL) to which 7.0 mmol/L **1** in MeOH (15 µL) had been added. The medium was incubated for 3--24 h at 27 °C with reciprocal shaking at 200 strokes/min.

3.5. Screening of the Sakuranetin *(**1**)* Metabolites from the Rhizoctonia solani Suspension Culture {#sec3dot5-molecules-23-00276}
------------------------------------------------------------------------------------------------------

Following the addition of **1**, the medium (1 mL) was incubated for 0 or 12 h and then diluted with MeOH (8 mL). The extract was filtered through a cotton-plugged Pasteur pipette. The filtrate was evaporated to dryness in vacuo, the residue was dissolved in 800 µL of MeOH, and the resulting solution was filtered through a 0.22-µm membrane filter. A 10-µL aliquot of the solution was subjected to LC-MS analysis to detect the putative metabolites of **1**. The Turbo V ion source was operated in the positive electrospray ionization (ESI) mode. LC separation of the analytes was achieved on a Unison UK-18 column (150 × 2.0 mm i.d., 3.0 µm particle size; Imtact Co., Kyoto, Japan) with a binary gradient of 0.1% (*v*/*v*) aqueous HCOOH (solvent A) and MeOH containing 0.1% HCOOH (solvent B) at a flow rate of 0.2 mL/min at 40 °C. The solvent gradient elution was performed with the following program: (i) initial, 20% B; (ii) 0--5 min, isocratic elution with 20% B; (iii) 5--25 min, a linear gradient from 20% B to 100% B; and (iv) 25--30 min, isocratic elution with 100% B. The following parameters were used for the ion source and MS: (i) curtain gas (CUR), 20 psi; (ii) temperature (TEM), 450 °C; (iii) nebulizer gas (GS1), 50 psi; (iv) GS2, 50 psi; (v) ion spray voltage (IS), 5200 V; (vi) declustering potential (DP), 51.0 V; and (vii) entrance potential (EP), 7.5 V. The scan range for the MS anaysis was set to *m*/*z* 100--700 (enhanced MS scan).

3.6. LC-MS/MS Analysis to Identify Naringenin *(**2**)* as a Metabolite {#sec3dot6-molecules-23-00276}
-----------------------------------------------------------------------

LC-ESI-CID-MS analysis was performed according to a previously described method \[[@B10-molecules-23-00276]\].

3.7. Purification of Sakuranetin-4′-O-β-[d]{.smallcaps}-xylopyranoside *(**3**)* and Naringenin-7-O-β-[d]{.smallcaps}-xylopyranoside *(**4**)* from the Rhizoctonia solani Suspension Culture {#sec3dot7-molecules-23-00276}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A portion of approximately 1 × 1 cm of the fungal layer was excised from the 5 dpi PDA medium. The fungal layer was homogenized using a spatula and suspended in PDB (300 mL). The fungal culture was incubated for 5 days in the dark at 27 °C with rotary shaking at 150 rpm. After the addition of 35 mmol/L **1** in MeOH (1 mL), the culture was incubated for 18 h under the same conditions. MeOH (200 mL) was added to the culture, and the mixture was homogenized with a Physcotron homogenizer (Microtec, Funabashi, Japan). The homogenate was filtered through filter paper, and the filtrate was concentrated in vacuo. The concentrate (250 mL) was extracted with EtOAc (250 mL × 3) and the organic layer was concentrated to dryness in vacuo. The residue of the EtOAc extract was dissolved in MeOH to a concentration of 4% (*v*/*v*) and separated on a Luna C18(2) column (25 × 1 cm i.d., 5 µm particle size, Phenomenex, Torrance, CA, USA) with a binary gradient of H~2~O (solvent A) and MeOH (solvent B) at a flow rate of 2 mL/min at 40 °C. The gradient elution was performed with the following program: (i) initial, 40% B; (ii) 0--50 min, isocratic elution with 40% B; (iii) 50--80 min, a linear gradient from 40% B to 70% B; and (iv) 80--100 min, isocratic elution with 40% B. The injection volume in each run was 50 µL, and the sample was separated repeatedly under the same conditions. The detection wavelength was 280 nm. The presence of **3** and **4** was confirmed using LC/MS under the same conditions as were used in the screening of the metabolites. The peak containing **3** (*t*~R~ 77--78 min) was collected and evaporated to dryness in vacuo to afford 1.1 mg of **3**. The peak containing **4** (*t*~R~ 43--46 min) was collected and evaporated to dryness in vacuo to afford 2.4 mg of **4**.

*Sakuranetin-4′-O-β-[d]{.smallcaps}-xylopyranoside* (**3**). HRMS (FAB): *m*/*z* 417.1172 (\[M − H\]^−^); calcd. for C~21~H~21~O~9~, 417.1185. ^1^H and ^13^C NMR (methanol-*d*~4~): see [Table 1](#molecules-23-00276-t001){ref-type="table"}; UV (MeOH) λ~max~ (log ε): 288 (4.0).

*Naringenin-7-O-β-[d]{.smallcaps}-xylopyranoside* (**4**). HRMS (FAB): *m*/*z* 403.1042 (\[M − H\]^−^); calcd. for C~20~H~19~O~9~, 403.1029. ^1^H and ^13^C NMR (acetone-*d*~6~): see [Table 1](#molecules-23-00276-t001){ref-type="table"}. UV (MeOH) λ~max~ (log ε): 283 (4.3).

3.8. GC-MS Analysis of the Hydrolysates of Sakuranetin-4′-O-β-[d]{.smallcaps}-xylopyranoside *(**3**)* and Naringenin-7-O-β-[d]{.smallcaps}-xylopyranoside *(**4**)* {#sec3dot8-molecules-23-00276}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------

The hydrolysis reaction was performed according to a previous study \[[@B17-molecules-23-00276]\]. Compound **3** or **4** (1 µg) was hydrolyzed with 40 µL of 2 mol/L TFA at 100 °C for 2 h. The hydrolysate mixture was concentrated to dryness in vacuo. The residue was trimethylsilylated with 50 µL of BSTFA + TMCS (99:1) at 70 °C for 3 h. The trimethylsilylated sample (2 µL) was subjected to GC-MS analysis. GC separation was carried out on a Zebron ZB-5MS column (30 m × 0.25 mm i.d., 0.25 µm film thickness, Phenomenex) under the following conditions: injector temperature, 280 °C; carrier gas, helium; and flow rate, 1.0 mL/min. The temperature program of the column oven was set to hold at 70 °C for 1 min, then increase at 10 °C/min to 300 °C, and finally hold at 300 °C for 3 min. The conditions used for the mass spectrometer were as follows: ionization mode, EI (70 eV); ion source temperature, 200 °C; scan range, *m*/*z* 61--760; and scan rate, 1 s/scan.

3.9. Quantitation of Sakuranetin *(**1**)* and Its Metabolites in the Rhizoctonia solani Suspension Culture {#sec3dot9-molecules-23-00276}
-----------------------------------------------------------------------------------------------------------

After incubation, MeOH (8 mL) was added to the medium (1 mL), and the resulting suspension was shaken for 1 h. The extract was filtered through a cotton-plugged Pasteur pipette and a membrane filter (0.22 µm). A portion of the filtrate (0.1 mL) was diluted with MeOH (0.9 mL), and 2 µL of the dilution was subjected to LC-MS/MS analysis. The Turbo V ion source was operated in the negative ESI mode. LC separation of the analytes was achieved on a TSK-gel ODS-100V column (50 × 2.0 mm i.d., 3.0 µm particle size; Tosoh Corp., Tokyo, Japan) with a binary gradient of 0.1% (*v*/*v*) aqueous HCOOH (solvent A) and MeOH containing 0.1% HCOOH (solvent B) at a flow rate of 0.2 mL/min at 40 °C. The solvent gradient elution was performed according to the following program: (i) initial, 20% B; (ii) 0--1 min, isocratic elution with 20% B; (iii) 1--6 min, a linear gradient from 20% B to 100% B; and (iv) 6--9 min, isocratic elution with 100% B. The following parameters were used for the ion source: (i) CUR, 10 psi; (ii) TEM, 300 °C; (iii) GS1, 30 psi; (iv) GS2, 80 psi; and (v) IS, −4500 V. The selective reaction monitoring (SRM) transitions and MS parameters were optimized to detect **1**--**4** using Analyst 1.6.2 software (SCIEX). The following SRM transitions (*t*~R~) were monitored: (**1**) *m*/*z* 285 → 119 (7.3 min), (**2**) *m*/*z* 271 → 151 (6.6 min), (**3**) *m*/*z* 417 → 285 (6.9 min), and (**4**) *m*/*z* 403 → 271 (6.1 min). The optimized MS parameters for each compound were as follows: (**1**) −45 V DP, −4.5 V EP, and −24 V CE; (**2**) −45 V DP, −6.5 V EP, and −22 V CE; (**3**) −60 V DP, −3 V EP, and --18 V CE; and (**4**) −40 V DP, −3.5 EP, and −22 CE. Calibration curves were prepared using the SRM peak areas of standards for **1** and **2**--**4** in concentration ranges of 20--2000 ng/mL and 10--1000 ng/mL, respectively.

3.10. Assay of the Antifungal Activity Against Rhizoctonia solani {#sec3dot10-molecules-23-00276}
-----------------------------------------------------------------

The Fungal colony growth inhibition assay was performed according to a previously described method, which used *Pyricularia oryzae* as the test fungus \[[@B18-molecules-23-00276]\]. In this study, *R. solani* was used instead of *P*. *oryzae*.

4. Conclusions {#sec4-molecules-23-00276}
==============

Xylosylated flavanones sakuranetin-4′-*O*-β-[d]{.smallcaps}-xylopyranoside (**3**) and naringenin-7-*O*-β-[d]{.smallcaps}-xylopyranoside (**4**) as well as naringenin (**2**) were identified as detoxified metabolites of sakuranetin (**1**) by the rice sheath blight fungus *Rhizoctonia solani*. Compound **2** is a common detoxified metabolite of **1** by both *R*. *solani* and *Pyricularia oryzae*. However, xylosylation by *R*. *solani* is a rare and efficient detoxification path of phytoalexins.

**Sample Availability:** Samples of the compounds **3** and **4** are available from the authors.

Supplementary materials are available online.
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![Time-dependent decrease in sakuranetin (**1**) content in the *Rhizoctonia solani* suspension culture. Values are reported as the mean ± SD (*n* = 3).](molecules-23-00276-g002){#molecules-23-00276-f002}

![Total ion current chromatograms obtained from the *Rhizoctonia solani* suspension cultures containing sakuranetin (**1**) using LC-MS. (**a**) Chromatogram after 0 h of incubation following the addition of **1**; (**b**) 12 h of incubation after the addition of **1**.](molecules-23-00276-g003){#molecules-23-00276-f003}

![ESI-CID-MS results of a potential metabolite (peak II) in the *Rhizoctonia solani* suspension culture containing sakuranetin (**1**) and naringenin (**2**). (**a**) Peak II; (**b**) naringenin (**2**).](molecules-23-00276-g004){#molecules-23-00276-f004}

![Key 2D NMR correlations for compounds **3** and **4**. The COSY and TOCSY correlations are represented by bold lines, and the HMBC are represented by arrows from H to C.](molecules-23-00276-g005){#molecules-23-00276-f005}

![Time-dependent accumulations of naringenin (**2**), sakuranetin-4′-*O*-β-[d]{.smallcaps}-xylopyranoside (**3**), and naringenin-7-*O*-β-[d]{.smallcaps}-xylopyranoside (**4**), and the decreasing sakuranetin (**1**) content in the *Rhizoctonia solani* suspension culture. Values are presented as the mean ± SD (*n* = 3).](molecules-23-00276-g006){#molecules-23-00276-f006}

![Antifungal activities of **1**, **2**, **3**, and **4** (300 µmol/L) against *Rhizoctonia solani* mycelium growth. Values are presented as the mean ± SD (*n* = 4).](molecules-23-00276-g007){#molecules-23-00276-f007}
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###### 

^13^C and ^1^H NMR data for compounds **3** (methanol-*d*~4~) and **4** (acetone-*d*~6~).

  Position                Compound 3                       Compound 4                                  
  ----------------------- -------------------------------- ----------------------- ------------------- -----------------------------------
  2                       80.2                             5.45 (dd, 12.7, 3.1)    80.15/80.17 ^1^     5.50 (dd, 13.0, 3.2)
  3                       44.1                             2.79 (dd, 17.2, 3.1)    43.58/43.60 ^1^     2.78 (m) ^2^
  3.14 (dd, 17.2, 12.7)   3.24/3.25 ^1^ (dd, 17.0, 13.0)                                               
  4                       197.9                                                    197.97/197.99 ^1^   
  5                       165.3                                                    164.72/164.76 ^1^   
  6                       95.8                             6.05 (d, 2.3)           97.6                6.11/6.12 ^1^ (d, 2.2)
  7                       169.6                                                    166.46/166.53 ^1^   
  8                       95.0                             6.08 (d, 2.3)           96.4                6.15 (d, 2.2)
  9                       164.6                                                    164.2               
  10                      104.1                                                    104.5               
  7-*O*-Me                56.3                             3.81 (s)                --                  --
  5-OH                    --                               --                                          12.07
  1′                      134.2                                                    130.63/130.67 ^1^   
  2′, 6′                  128.8                            7.44 (d, 8.7)           129.10/129.14 ^1^   7.41 (d, 8.7)
  3′, 5′                  117.9                            7.11 (d, 8.7)           116.3               6.91 (d, 8.7)
  4′                      159.2                                                    158.84/158.85 ^1^   
  1″                      102.8                            4.90 (d, 7.2)           101.39/101.46 ^1^   5.06/5.07 ^1^ (d, 7.0 or 5.8) ^3^
  2″                      74.7                             3.44 (m)^2^             74.1                3.48 (m) ^2^
  3″                      77.7                             3.44 (m)^2^             77.4                3.48 (m) ^2^
  4″                      71.0                             3.57 (m)                70.6                3.60 (m)
  5″                      66.9                             3.37 (dd, 11.4, 10.2)   66.6                3.50 (m) ^2^
  3.92 (dd, 11.4, 5.3)    3.91 (dd, 11.2, 4.8)                                                         

^1^ Each diastereomer showed different chemical shifts. ^2^ The chemical shifts were estimated by an HSQC experiment. ^3^ Two possibilities are listed for the *J* values; the true values could not be confidently assigned due to the overlapping signals of the two diastereomers.
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###### 

Inhibitory activity of **1**, **2**, **3**, and **4** on *Rhizoctonia solani* mycelium growth after 48 h of incubation.

  Compound   Concentration (µmol/L)                     
  ---------- ------------------------ ----------------- -----------------
  **1**      9.8 ± 0.6 (31)           8.1 ± 0.7 (42)    6.8 ± 1.2 (52)
  **2**      14.5 ± 0.6 (−3)          11.3 ± 0.2 (20)   10.6 ± 0.5 (25)
  **3**      12.8 ± 0.2 (10)          13.1 ± 0.9 (7)    12.9 ± 0.2 (9)
  **4**      14.4 ± 0.2 (−2)          14.0 ± 0.2 (1)    14.0 ± 0.8 (1)

Values are presented as the mean ± SD (*n* = 4). Inhibition \[%\] = (1-colony length of sample/colony length of control) × 100. Colony length of the control was 14.1 ± 1.0 mm.
